Both Trump and Harris seek to lower drug costs for patients. What headway have they made on realizing this goal?
Articles on Prescription drugs
Displaying 21 - 40 of 110 articles
If you want to know more about a drug, Health Canada provides information online through several websites. However, some information appears to be getting harder to find.
The way pharmacare is implemented could contribute to the Canadian health insurance system’s transition toward a more contentious and unequal American-style system with heavy administrative burdens.
Taking a medicine with alcohol can increase effects like sedation, poor hand and eye coordination, dizziness and poor judgement.
Pharmaceutical and insurance industries that could lose profit through lower drug prices are not happy that a pharmacare bill is planned for fall. They are speaking out and mobilizing their allies.
Not enough data is being collected about the impact taking prescription medication has on breastfeeding.
The federal government’s proposed Agile Licensing drug approval regulations mean Canada will have less information about the risks of new medicines, and higher costs.
The proposed plans will likely benefit patients – but only if more is done to ensure pharmacists can provide these additional services.
Don’t be intimidated by the package insert that comes with your medication. Learning how to read it can help you better understand how drugs work.
The pharma industry claims lower prescription drug prices will mean less access to new medication for Canadians. It’s an old threat that pits profits against patients’ rights to affordable drugs.
It is illegal to share prescription drugs with friends and family.
Prescription opiods, stimulants such as those used to treat ADHD and the ingredients found in sexual dysfunction drugs like Viagra are some of the drugs that are being marketed to US consumers.
About 1 in 4 Americans with diabetes who need insulin struggle to pay for this lifesaving drug.
Products aimed at sexual dysfunction and weight loss were the most common dietary supplements that contained hidden – and potentially harmful – ingredients.
Canada lags behind other developed countries in access to newer antimicrobials. Here’s why that matters, and what can be done about it.
Generic drug names are often long, but they can tell doctors what type of medicine it is and how it works. But it’s brand names that appear first and most prominently in Health Canada materials.
Tylenol has long been considered a go-to medication for low to moderate pain and for fever reduction, even during pregnancy. But mounting evidence suggests that it is unsafe for fetal development.
Energy drinks and coffee both contain lots of caffeine. That’s a problem for teens, especially those who take prescription stimulants.
Side-effects for this unproven and potentially dangerous treatment range from vomiting and diarrhoea to seizures and a coma.
Ending the opioid epidemic requires addressing not only treatment gaps in addiction and overdose, but also inadequate pain management.
Top contributors
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Distinguished Professor of Pharmacy Practice, University of Connecticut
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate Professor in Pharmacy Practice, Kingston University
-
Associate Professor in Pharmacy Practice, University of Bradford
-
Professor of Health Service Operations, School of Pharmacy & Medical Sciences, University of Bradford
-
University of Oxford
-
Professor of Health Law and Bioethics, Case Western Reserve University
-
Head of School and Dean of Pharmacy, University of Sydney
-
Associate Professor, Political Science, McMaster University
-
Associate Professor of Public Health, The Ohio State University
-
Doctoral Student in Biochemistry, University of Washington
-
Assistant Professor, Johns Hopkins University
-
Director of Health Policy, USC Schaeffer Center, and Associate Professor, University of Southern California
-
Senior research scholar and lecturer, Princeton Environmental Institute, Princeton University